Cargando…

From fixed activities to personalized treatments in radionuclide therapy: lost in translation?

Detalles Bibliográficos
Autores principales:	Flux, G. D., Sjogreen Gleisner, K., Chiesa, C., Lassmann, M., Chouin, N., Gear, J., Bardiès, M., Walrand, S., Bacher, K., Eberlein, U., Ljungberg, M., Strigari, L., Visser, E., Konijnenberg, M. W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700228/ https://www.ncbi.nlm.nih.gov/pubmed/29080096 http://dx.doi.org/10.1007/s00259-017-3859-1

Ejemplares similares

EANM dosimetry committee series on standard operational procedures: a unified methodology for (99m)Tc-MAA pre- and (90)Y peri-therapy dosimetry in liver radioembolization with (90)Y microspheres
por: Chiesa, Carlo, et al.
Publicado: (2021)

Hybrid Imaging for Patient-Specific Dosimetry in Radionuclide Therapy
por: Ljungberg, Michael, et al.
Publicado: (2015)

Personalized Dosimetry for Radionuclide Therapy Using Molecular Imaging Tools
por: Ljungberg, Michael, et al.
Publicado: (2016)

EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
por: Sjögreen Gleisner, Katarina, et al.
Publicado: (2022)

EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations
por: Gear, Jonathan I., et al.
Publicado: (2018)

Feasibility of simplifying renal dosimetry in (177)Lu peptide receptor radionuclide therapy
por: Sundlöv, Anna, et al.
Publicado: (2018)

SPECT image segmentation for estimation of tumour volume and activity concentration in (177)Lu-DOTATATE radionuclide therapy
por: Gustafsson, Johan, et al.
Publicado: (2017)

Dosimetry-based treatment planning for molecular radiotherapy: a summary of the 2017 report from the Internal Dosimetry Task Force
por: Stokke, Caroline, et al.
Publicado: (2017)

Variations in the practice of molecular radiotherapy and implementation of dosimetry: results from a European survey
por: Sjögreen Gleisner, Katarina, et al.
Publicado: (2017)

Monte Carlo modelling of a compact CZT-based gamma camera with application to (177)Lu imaging
por: Roth, Daniel, et al.
Publicado: (2022)

GATE/Geant4-based dosimetry for ex vivo in solution irradiation of blood with radionuclides
por: Salas-Ramirez, Maikol, et al.
Publicado: (2022)

Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine – a review
por: Eberlein, Uta, et al.
Publicado: (2011)

EANM Dosimetry Committee series on standard operational procedures for internal dosimetry for (131)I mIBG treatment of neuroendocrine tumours
por: Gear, Jonathan, et al.
Publicado: (2020)

Inter-comparison of quantitative imaging of lutetium-177 ((177)Lu) in European hospitals
por: Wevrett, Jill, et al.
Publicado: (2018)

Setting up a quantitative SPECT imaging network for a European multi-centre dosimetry study of radioiodine treatment for thyroid cancer as part of the MEDIRAD project
por: Taprogge, Jan, et al.
Publicado: (2020)

EANM position paper on the role of radiobiology in nuclear medicine
por: Aerts, An, et al.
Publicado: (2021)

Individualised (177)Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
por: Sundlöv, Anna, et al.
Publicado: (2017)

Internal microdosimetry of alpha-emitting radionuclides
por: Hofmann, Werner, et al.
Publicado: (2019)

DNA damage in blood lymphocytes in patients after (177)Lu peptide receptor radionuclide therapy
por: Eberlein, Uta, et al.
Publicado: (2015)

Lost in Translation: Obstacles to Translational Medicine
por: Mankoff, Stacey P, et al.
Publicado: (2004)

Lost in translation
por: Petsko, Gregory A
Publicado: (2010)

Lost in Translation
por: Wasserman, David H., et al.
Publicado: (2009)

Lost in translation
por: Nachev, Parashkev, et al.
Publicado: (2019)

Lost in translation
por: Millard, Lee, et al.
Publicado: (2023)

Renal and Red Marrow Dosimetry in Peptide Receptor Radionuclide Therapy: 20 Years of History and Ahead
por: Walrand, Stephan, et al.
Publicado: (2021)

An EANM position paper on advancing radiobiology for shaping the future of nuclear medicine
por: Pouget, Jean-Pierre, et al.
Publicado: (2022)

Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based (177)Lu-DOTATATE treatment of NET patients
por: Sundlöv, Anna, et al.
Publicado: (2022)

Lost in Translation (LiT)
por: Dollery, Colin T
Publicado: (2014)

Tumor Immunotargeting Using Innovative Radionuclides
por: Kraeber-Bodéré, Françoise, et al.
Publicado: (2015)

Characterisation of a hand-held CZT-based gamma camera for (177)Lu imaging
por: Roth, Daniel, et al.
Publicado: (2020)

Lost in translation: the signal hypothesis
por: Leslie, Mitch
Publicado: (2005)

COPD exacerbation: Lost in translation
por: Makris, Demosthenes, et al.
Publicado: (2009)

Nrf2: not “lost in translation”
por: Hawley, Robert G., et al.
Publicado: (2016)

Alcoholic Hepatitis: Lost in Translation
por: Woolbright, Benjamin L., et al.
Publicado: (2017)

Hypoglycemia, Something Lost in Translation
por: Al-Naqeeb, Ghadah, et al.
Publicado: (2021)

Kardiale Zelltherapie – „lost in translation?“
por: Stamm, Christof
Publicado: (2022)

Lost in Translation – What is Alexithymia
por: Morais, A.S., et al.
Publicado: (2022)

Combining Targeted Radionuclide Therapy and Immune Checkpoint Inhibition for Cancer Treatment
por: Kleinendorst, Simone C., et al.
Publicado: (2022)

Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD project
por: Taprogge, Jan, et al.
Publicado: (2023)

The ventromedial prefrontal cortex and emotion regulation: lost in translation?
por: Alexander, Laith, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_taknlo52p0p2v0naudoshu3fil